{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Shattuck Labs, Inc.
Shattuck Labs, Inc. Hits New 52-Week High at $2.64
Shattuck Labs, Inc. has achieved a new 52-week high of USD 2.64, marking a significant recovery from its previous low of USD 0.69. Despite this milestone, the company has experienced a 61.34% decline over the past year and remains loss-making, with a market capitalization of approximately USD 90 million.
Shattuck Labs Forms Golden Cross, Signaling Potential Bullish Breakout Ahead
Shattuck Labs, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. While the stock has faced a challenging year, it has shown resilience with a notable year-to-date increase. Technical indicators present a mixed outlook, suggesting cautious optimism as the company navigates the biotechnology sector.
Is Shattuck Labs, Inc. technically bullish or bearish?
As of September 10, 2025, Shattuck Labs, Inc. shows a neutral technical trend with mixed signals, outperforming the S&P 500 in the short term but underperforming over the past year.
Is Shattuck Labs, Inc. overvalued or undervalued?
As of November 9, 2023, Shattuck Labs, Inc. is considered overvalued and classified as risky due to its poor financial metrics and significant long-term stock volatility, despite a recent strong performance.
Is Shattuck Labs, Inc. overvalued or undervalued?
As of November 9, 2023, Shattuck Labs, Inc. is considered "risky" and overvalued due to negative financial metrics, including a -104.36% return on equity and poor performance compared to peers and the S&P 500.
Is Shattuck Labs, Inc. technically bullish or bearish?
As of June 11, 2025, the technical trend is mildly bearish, indicated by daily moving averages and monthly bearish signals, despite some bullish indicators in longer time frames.
Who are in the management team of Shattuck Labs, Inc.?
As of March 2022, the management team of Shattuck Labs, Inc. includes Executive Chairman and Co-Founder Mr. Josiah Hornblower and Chief Executive Officer, Co-Founder, and Director Mr. Taylor Schreiber.
What does Shattuck Labs, Inc. do?
Shattuck Labs, Inc. is a clinical-stage biotechnology company focused on developing dual-sided fusion proteins. As of March 2025, it has a market cap of $46.58 million and reported a net profit loss of $14 million.
How big is Shattuck Labs, Inc.?
As of Jun 18, Shattuck Labs, Inc. has a market capitalization of 46.58 million and reported net sales of 4.61 million with a net profit of -70.61 million over the last four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
